Sign in
Active, not recruitingNo phase

Clinical Trial of a Group Self-management Support Program for Anxiety Disorders

Key facts

Who runs it
Université de Sherbrooke
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
414 people enrolled
Started
6 Oct 2022
Expected to end
21 Dec 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Group self-management support program for anxiety disorders
Record updated
9 May 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • (1) aged 18 and over,
  • (2) fluent in spoken and written French,
  • (3) presence of symptoms of anxiety disorders based on self-reported validated assessment scales and semi-structured assessment interview,
  • (4) access to a computer or tablet connected to the internet with microphone and video camera

Who cannot take part

  • (1) previous enrolment in the SMS intervention provided by Relief
  • (4) active substance-related and addictive disorder,
  • (5) cognitive impairment
  • (2) active suicidal intentions,
  • (3) severe depressive symptoms,

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Background. Self-management support is a complementary approach to treatment that aims to educate participants on the nature of anxiety and to improve their strategies to manage symptoms and well-being, thus presenting the potential to enhance recovery, improve outcomes, reduce recurrence rates and lower health care costs. There is limited evidence to support the effectiveness of group self-management support for anxiety disorders in community-based care.

Read full original descriptionShow less

Objectives. This study aims at examining the effectiveness of a virtual group self-management support program (SMS) for anxiety disorders as an add-on to treatment-as-usual (TAU) in community-based care settings. We will also assess the incremental cost/effectiveness ratio and the implementability of the intervention.

Methods. The trial is a pragmatic randomized controlled trial with a pre-treatment, post-treatment (4-month post-randomization), and follow-ups at 8, 12 and 24-months. Intervention. The experimental condition will consist of a 10-week SMS program for anxiety disorders in addition to TAU. The control condition will receive TAU without restrictions for anxiety disorders. Inclusion criteria will comprise being 18 years old or older, French-speaking, and presenting symptoms of anxiety disorders based on self-reported validated assessment scales. Patients will be recruited in the province of Quebec (Canada). Outcome measures: The primary outcome measure is the Beck Anxiety Inventory (BAI). The secondary outcome measures include self-reported instruments for anxiety and depressive symptoms, recovery, self-management, quality of life, and service utilisation. Statistical analysis: Intention-to-treat analysis. A mixed effects regression model will be used to account for between and within-subject variations in the analysis of the longitudinal effects of the intervention.

Expected outcomes. The rigorous evaluation of the SMS intervention in the real world will provide information to decision makers, health care managers, clinicians and patients regarding the added value of group SMS for patients with anxiety disorders. Widespread implementation of this intervention could lead to more efficient mental health care services, to better long-term outcomes and to a significant reduction in the extensive social and economic burden of anxiety disorders.

The 2 groups in the trial

  • Group self-management supportTreatment being tested

    Group self-management support program for anxiety disorders developped by Relief (https://myrelief.ca/).

    Treatment: Group self-management support program for anxiety disorders

  • Treatment-as-usualNo study treatment, for comparison

    Treatment-as-usual and a delayed intervention (if desired by participants) after the 12-month follow up

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Pragmatic Randomized Controlled Trial of a Group Self-management Support Program Versus Treatment-as-usual for Anxiety Disorders
Publications
Record updated
9 May 2024